First National Trust Co Decreases Stock Holdings in CVS Health Co. (NYSE:CVS)

First National Trust Co trimmed its position in CVS Health Co. (NYSE:CVS) by 22.7% during the 4th quarter, Holdings Channel reports. The institutional investor owned 8,798 shares of the pharmacy operator’s stock after selling 2,577 shares during the period. First National Trust Co’s holdings in CVS Health were worth $395,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Intact Investment Management Inc. increased its position in CVS Health by 240.8% during the 4th quarter. Intact Investment Management Inc. now owns 274,000 shares of the pharmacy operator’s stock valued at $12,300,000 after purchasing an additional 193,600 shares during the period. Aviso Financial Inc. increased its position in CVS Health by 52.6% during the 4th quarter. Aviso Financial Inc. now owns 14,104 shares of the pharmacy operator’s stock valued at $633,000 after purchasing an additional 4,862 shares during the period. LBP AM SA bought a new stake in shares of CVS Health during the 4th quarter valued at $6,541,000. Madison Investment Advisors LLC bought a new stake in shares of CVS Health during the 4th quarter valued at $6,233,000. Finally, Thompson Siegel & Walmsley LLC boosted its holdings in shares of CVS Health by 31.8% during the 4th quarter. Thompson Siegel & Walmsley LLC now owns 126,506 shares of the pharmacy operator’s stock valued at $5,679,000 after buying an additional 30,520 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have recently commented on CVS. Leerink Partnrs upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 12th. Wells Fargo & Company boosted their target price on CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 30th. Cantor Fitzgerald raised shares of CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday, February 12th. Finally, Argus set a $77.00 price target on shares of CVS Health in a research report on Tuesday, February 18th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $69.83.

Insider Activity

In related news, SVP James David Clark sold 7,513 shares of the firm’s stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael F. Mahoney purchased 30,000 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was bought at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.24% of the company’s stock.

CVS Health Trading Down 0.2 %

CVS stock opened at $65.63 on Friday. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The company has a market capitalization of $82.75 billion, a price-to-earnings ratio of 17.93, a PEG ratio of 0.98 and a beta of 0.53. The business has a 50 day simple moving average of $58.47 and a two-hundred day simple moving average of $56.98.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Research analysts anticipate that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.05%. CVS Health’s dividend payout ratio is currently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.